Rare diseases
Investigational molecules
Locations
Back to Italy46 clinical trials in Misterbianco, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer
ItalyStudy of DCC-3116 with Sotorasib, Binimetinib, and Trametinib for Patients with Advanced or Metastatic Solid Tumors with RAS/MAPK Pathway Mutations
ItalyStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
ItalyStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
ItalyStudy Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment
ItalyStudy of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer
ItalyStudy on the Safety and Antitumor Activity of ARV-471 and Ribociclib in Adults with ER+ Advanced or Metastatic Breast Cancer
ItalyStudy Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy
ItalyStudy Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment
ItalyStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer treatments. Studies evaluate novel therapeutic combinations including targeted therapies and endocrine treatments.
Innovative approaches combining established treatments with new compounds to improve patient outcomes.
Research focusing on advanced pancreatic cancer and gastric cancer treatments, evaluating new combination therapies and maintenance strategies.
Studies aim to improve survival rates through innovative treatment combinations and maintenance strategies.
Clinical trials investigating treatments for Non-Small Cell Lung Cancer (NSCLC), including targeted therapies and immunotherapy combinations.
Focus on personalized treatment approaches based on specific genetic markers and disease stages.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
